Skip to content

Title 21 — Food and Drugs

Chapter 25 — Miscellaneous Anti-Drug Abuse Provisions

§ 2001. Designation of United States Anti-Doping Agency

Statutory text

(a)

Definitions

In this subchapter:

(1)

United States Olympic Committee

The term “United States Olympic Committee” means the organization established by the “Ted Stevens Olympic and Amateur Sports Act” (36 U.S.C. 220501 et seq.).

(2)

Amateur athletic competition

The term “amateur athletic competition” means a contest, game, meet, match, tournament, regatta, or other event in which amateur athletes compete (36 U.S.C. 220501(b)(2)).

(3)

Amateur athlete

The term “amateur athlete” means an athlete who meets the eligibility standards established by the national governing body or paralympic sports organization for the sport in which the athlete competes (36 U.S.C. 22501(b)(1)).1

(b)

In general

The United States Anti-Doping Agency shall—

(1)
(A)

serve as the independent anti-doping organization for the amateur athletic competitions recognized by the United States Olympic and Paralympic Committee;

(B)

be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within the jurisdiction of the United States; and

(C)

be recognized worldwide as the independent national anti-doping organization for the United States;

(2)

ensure that athletes participating in amateur athletic activities recognized by the United States Olympic Committee are prevented from using performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency;

(3)

implement anti-doping education, research, testing, and adjudication programs to prevent United States Amateur Athletes participating in any activity recognized by the United States Olympic Committee from using performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency;

(4)

serve as the United States representative responsible for coordination with other anti-doping organizations coordinating amateur athletic competitions recognized by the United States Olympic Committee to ensure the integrity of athletic competition, the health of the athletes, and the prevention of use by United States amateur athletes of performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency; and

(5)

promote a positive youth sport experience by using a portion of the funding of the United States Anti-Doping Agency to provide educational materials on sportsmanship, character building, and healthy performance for the athletes, parents, and coaches who participate in youth sports.

(c)

Due process in arbitration proceedings

Any action taken by the United States Anti-Doping Agency to enforce a policy, procedure, or requirement of the United States Anti-Doping Agency against a person with respect to a violation of Federal law, including an investigation, a disciplinary action, a sanction, or any other administrative action, shall be carried out in a manner that provides due process protection to the person.

Footnotes

  1. 1 So in original. Probably should be “220501(b)(1)).”

Legislative history

Reconstructed from this section’s Code source credit and amendment notes, resolved against the local Statutes at Large. Editorial notes are evidence, not the law that made the change.

  1. Office of National Drug Control Policy Reauthorization Act of 2006

    Pub. L. 109–469 title VII § 701 · 120 Stat. 3502

    Enacted · 21 U.S.C. § 2001

    Pub. L. 109–469, title VII, § 701, Dec. 29, 2006, 120 Stat. 3533

    Source evidence

    Code source credit
    Pub. L. 109–469, title VII, § 701, Dec. 29, 2006, 120 Stat. 3533

    Enacted provision · exact public law section
    SEC. 701. DESIGNATION OF UNITED STATES ANTI-DOPING AGENCY. (a) Definitions.— In this title: (1) United states olympic committee.— The term “United States Olympic Committee” means the organization established by the “Ted Stevens Olympic and Amateur Sports Act” (36 U.S.C. 220501 et seq.). (2) Amateur athletic competition.— The term “amateur athletic competition” means a contest, game, meet, match, tournament, regatta, or other event in which amateur athletes compete (36 U.S.C. 220501(b)(2)). (3) Amateur athlete.— The term “amateur athlete” means an athlete who meets the eligibility standards established by the national governing body or paralympic sports organization for the sport in which the athlete competes (36 U.S.C. 22501(b)(1)). (4) Gene doping.— The term “gene doping” means the nontherapeutic use of cells, genes, genetic elements, or of the modulation of gene expression, having the capacity to enhance athletic performance. (b) In General.— The United States Anti-Doping Agency shall— (1) serve as the independent anti-doping organization for the amateur athletic competitions recognized by the United States Olympic Committee; (2) ensure that athletes participating in amateur athletic activities recognized by the United States Olympic Committee are prevented from using performance-enhancing drugs, or performance-enhancing genetic modifications accomplished through gene-doping; (3) implement anti-doping education, research, testing, and adjudication programs to prevent United States Amateur Athletes participating in any activity recognized by the United States Olympic Committee from using performance-enhancing drugs, or performance-enhancing genetic modifications accomplished through gene-doping; (4) serve as the United States representative responsible for coordination with other anti-doping organizations coordinating amateur athletic competitions recognized by the United States Olympic Committee to ensure the integrity of athletic competition, the health of the athletes and the prevention of use of performance-enhancing drugs, or performance-enhancing genetic modifications accomplished through gene-doping by United States amateur athletes; and (5) permanently include “gene doping” among any list of prohibited substances adopted by the Agency.

  2. United States Anti-Doping Agency Reauthorization Act

    Pub. L. 113–280 § 2(1) · 128 Stat. 3020

    Struck · 21 U.S.C. § 2001(a)(4)

    Pub. L. 113–280, § 2(1), struck out par. (4). Text read as follows: “The term ‘gene doping’ means the nontherapeutic use of cells, genes, genetic elements, or of the modulation of gene expression, having the capacity to enhance athletic performance.”

    Source evidence

    Code amendment note
    Subsec. (a)(4). Pub. L. 113–280, § 2(1), struck out par. (4). Text read as follows: “The term ‘gene doping’ means the nontherapeutic use of cells, genes, genetic elements, or of the modulation of gene expression, having the capacity to enhance athletic performance.”

    Enacted provision · exact public law section
    (1) in subsection (a), by striking paragraph (4); and

  3. United States Anti-Doping Agency Reauthorization Act

    Pub. L. 113–280 § 2(2)(A) · 128 Stat. 3020

    Inserted · 21 U.S.C. § 2001(b)(1)

    Pub. L. 113–280, § 2(2)(A), inserted “and be recognized worldwide as the independent national anti-doping organization for the United States” after “Committee”

    Source evidence

    Code amendment note
    Subsec. (b)(1). Pub. L. 113–280, § 2(2)(A), inserted “and be recognized worldwide as the independent national anti-doping organization for the United States” after “Committee”.

    Enacted provision · exact public law section
    (A) in paragraph (1), by inserting “and be recognized worldwide as the independent national anti-doping organization for the United States” after “Committee”;

  4. United States Anti-Doping Agency Reauthorization Act

    Pub. L. 113–280 § 2(2)(B) · 128 Stat. 3020

    Substituted · 21 U.S.C. § 2001(b)(2)

    Pub. L. 113–280, § 2(2)(B), substituted “or prohibited performance-enhancing methods adopted by the Agency” for “, or performance-enhancing genetic modifications accomplished through gene-doping”

    Source evidence

    Code amendment note
    Subsec. (b)(2). Pub. L. 113–280, § 2(2)(B), substituted “or prohibited performance-enhancing methods adopted by the Agency” for “, or performance-enhancing genetic modifications accomplished through gene-doping”.

    Enacted provision · exact public law section
    (B) in paragraph (2), by striking “, or performance-enhancing genetic modifications accomplished through gene-doping” and inserting “or prohibited performance-enhancing methods adopted by the Agency”;

  5. United States Anti-Doping Agency Reauthorization Act

    Pub. L. 113–280 § 2(2)(C) · 128 Stat. 3020

    Substituted · 21 U.S.C. § 2001(b)(3)

    Pub. L. 113–280, § 2(2)(C), substituted “or prohibited performance-enhancing methods adopted by the Agency” for “, or performance-enhancing genetic modifications accomplished through gene-doping”

    Source evidence

    Code amendment note
    Subsec. (b)(3). Pub. L. 113–280, § 2(2)(C), substituted “or prohibited performance-enhancing methods adopted by the Agency” for “, or performance-enhancing genetic modifications accomplished through gene-doping”.

    Enacted provision · exact public law section
    (C) in paragraph (3), by striking “, or performance-enhancing genetic modifications accomplished through gene-doping” and inserting “or prohibited performance-enhancing methods adopted by the Agency”;

  6. United States Anti-Doping Agency Reauthorization Act

    Pub. L. 113–280 § 2(2)(D) · 128 Stat. 3020

    Substituted · 21 U.S.C. § 2001(b)(4)

    Pub. L. 113–280, § 2(2)(D), substituted “, and the prevention of use by United States amateur athletes of performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency.” for “and the prevention of use of performance-enhancing drugs, or performance-enhancing genetic modifications accomplished through gene-doping by United States amateur athletes; and”

    Source evidence

    Code amendment note
    Subsec. (b)(4). Pub. L. 113–280, § 2(2)(D), substituted “, and the prevention of use by United States amateur athletes of performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency.” for “and the prevention of use of performance-enhancing drugs, or performance-enhancing genetic modifications accomplished through gene-doping by United States amateur athletes; and”.

    Enacted provision · exact public law section
    (D) in paragraph (4), by striking “and the prevention of use of performance-enhancing drugs, or performance-enhancing genetic modifications accomplished through gene-doping by United States amateur athletes; and” and inserting “, and the prevention of use by United States amateur athletes of performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency.”; and

  7. United States Anti-Doping Agency Reauthorization Act

    Pub. L. 113–280 § 2(2)(E) · 128 Stat. 3020

    Struck · 21 U.S.C. § 2001(b)(5)

    Pub. L. 113–280, § 2(2)(E), struck out par. (5) which read as follows: “permanently include ‘gene doping’ among any list of prohibited substances adopted by the Agency.”

    Source evidence

    Code amendment note
    Subsec. (b)(5). Pub. L. 113–280, § 2(2)(E), struck out par. (5) which read as follows: “permanently include ‘gene doping’ among any list of prohibited substances adopted by the Agency.”

    Enacted provision · exact public law section
    (E) by striking paragraph (5).

  8. Energy and Water Development and Related Agencies Appropriations Act, 2022

    Pub. L. 117–103 § 303(1)(A) · 136 Stat. 49

    Amended · 21 U.S.C. § 2001(b)(1)

    Pub. L. 117–103, § 303(1)(A), amended par. (1) generally. Prior to amendment, par. (1) read as follows: “serve as the independent anti-doping organization for the amateur athletic competitions recognized by the United States Olympic Committee and be recognized worldwide as the independent national anti-doping organization for the United States;”

    Source evidence

    Code amendment note
    Subsec. (b)(1). Pub. L. 117–103, § 303(1)(A), amended par. (1) generally. Prior to amendment, par. (1) read as follows: “serve as the independent anti-doping organization for the amateur athletic competitions recognized by the United States Olympic Committee and be recognized worldwide as the independent national anti-doping organization for the United States;”.

    Enacted provision · exact public law section
    Sec. 303. None of the funds made available in this title shall be used for the construction of facilities classified as high-hazard nuclear facilities under 10 CFR Part 830 unless independent oversight is conducted by the Office of Enterprise Assessments to ensure the project is in compliance with nuclear safety requirements.

  9. Energy and Water Development and Related Agencies Appropriations Act, 2022

    Pub. L. 117–103 § 303(1)(B) · 136 Stat. 49

    Added · 21 U.S.C. § 2001(b)(5)

    Pub. L. 117–103, § 303(1)(B), (C), added par. (5)

    Source evidence

    Code amendment note
    Subsec. (b)(5). Pub. L. 117–103, § 303(1)(B), (C), added par. (5).

    Enacted provision · exact public law section
    Sec. 303. None of the funds made available in this title shall be used for the construction of facilities classified as high-hazard nuclear facilities under 10 CFR Part 830 unless independent oversight is conducted by the Office of Enterprise Assessments to ensure the project is in compliance with nuclear safety requirements.

  10. Energy and Water Development and Related Agencies Appropriations Act, 2022

    Pub. L. 117–103 § 303(2) · 136 Stat. 49

    Added · 21 U.S.C. § 2001(c)

    Pub. L. 117–103, § 303(2), added subsec. (c)

    Source evidence

    Code amendment note
    Subsec. (c). Pub. L. 117–103, § 303(2), added subsec. (c).

    Enacted provision · exact public law section
    Sec. 303. None of the funds made available in this title shall be used for the construction of facilities classified as high-hazard nuclear facilities under 10 CFR Part 830 unless independent oversight is conducted by the Office of Enterprise Assessments to ensure the project is in compliance with nuclear safety requirements.

10 of 10 references resolved to an enrolled provision

Editorial Notes

References in Text

The Ted Stevens Olympic and Amateur Sports Act, referred to in subsec. (a)(1), is chapter 2205 of Title 36, Patriotic and National Observances, Ceremonies, and Organizations.

Amendments2014–2022 · 2 rounds

2022

Subsec. (b)(1). Pub. L. 117–103, § 303(1)(A), amended par. (1) generally. Prior to amendment, par. (1) read as follows: “serve as the independent anti-doping organization for the amateur athletic competitions recognized by the United States Olympic Committee and be recognized worldwide as the independent national anti-doping organization for the United States;”.

Subsec. (b)(5). Pub. L. 117–103, § 303(1)(B), (C), added par. (5).

Subsec. (c). Pub. L. 117–103, § 303(2), added subsec. (c).

2014

Subsec. (a)(4). Pub. L. 113–280, § 2(1), struck out par. (4). Text read as follows: “The term ‘gene doping’ means the nontherapeutic use of cells, genes, genetic elements, or of the modulation of gene expression, having the capacity to enhance athletic performance.”

Subsec. (b)(1). Pub. L. 113–280, § 2(2)(A), inserted “and be recognized worldwide as the independent national anti-doping organization for the United States” after “Committee”.

Subsec. (b)(2). Pub. L. 113–280, § 2(2)(B), substituted “or prohibited performance-enhancing methods adopted by the Agency” for “, or performance-enhancing genetic modifications accomplished through gene-doping”.

Subsec. (b)(3). Pub. L. 113–280, § 2(2)(C), substituted “or prohibited performance-enhancing methods adopted by the Agency” for “, or performance-enhancing genetic modifications accomplished through gene-doping”.

Subsec. (b)(4). Pub. L. 113–280, § 2(2)(D), substituted “, and the prevention of use by United States amateur athletes of performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency.” for “and the prevention of use of performance-enhancing drugs, or performance-enhancing genetic modifications accomplished through gene-doping by United States amateur athletes; and”.

Subsec. (b)(5). Pub. L. 113–280, § 2(2)(E), struck out par. (5) which read as follows: “permanently include ‘gene doping’ among any list of prohibited substances adopted by the Agency.”

Statutory Notes and Related Subsidiaries

Change of Name

References to the United States Olympic Committee deemed to refer to the United States Olympic and Paralympic Committee, see section 220502(c) of Title 36, Patriotic and National Observances, Ceremonies, and Organizations.

Short Title of 2022 Amendment

Pub. L. 117–103, div. Q, title III, § 301, , 136 Stat. 816, provided that: “This title [enacting section 2004 of this title, amending this section and section 2003 of this title, and enacting provisions set out as a note below] may be cited as the ‘United States Anti-Doping Agency Reauthorization Act of 2022’.”

Short Title of 2014 Amendment

Pub. L. 113–280, § 1, , 128 Stat. 3020, provided that: “This Act [amending this section and section 2003 of this title] may be cited as the ‘United States Anti-Doping Agency Reauthorization Act’.”

Short Title

Pub. L. 109–469, title X, § 1001, , 120 Stat. 3537, provided that: “This title [enacting subchapter II of this chapter] may be cited as the ‘National Methamphetamine Information Clearinghouse Act of 2006’.”

Findings

Pub. L. 117–103, div. Q, title III, § 302, , 136 Stat. 816, provided that:

“Congress makes the following findings:

“(1)

The United States Anti-Doping Agency—

“(A)

is the independent national anti-doping organization of the United States; and

“(B)

manages the anti-doping program, results management processes, drug reference resources, and athlete education for all United States Olympic Committee-recognized national governing bodies and the athletes and events of such national governing bodies.

“(2)

The United States Anti-Doping Agency contributes to the advancement of clean sport through scientific research, anti-doping education, and outreach programs, and the mission of the United States Anti-Doping Agency is to preserve the integrity of competition and protect the rights of athletes.

“(3)

Participation in youth sports has the potential to equip young athletes with important skills and values necessary for success in life, and it is essential that the culture of youth sports emphasizes such skills and values.

“(4)

The TrueSport program of the United States Anti-Doping Agency partners with youth sport organizations across the United States to promote sportsmanship, character building, and healthy performance through the use of targeted educational materials designed to promote a positive youth sport experience.

“(5)

In modifying the authority of the United States Anti-Doping Agency to include the promotion of the positive values of youth sport, Congress sends a strong signal that the goals of youth sport should include instilling in young athletes the values of integrity, respect, teamwork, courage, and responsibility.

“(6)

Due to the unique leadership position of the United States in the global community, adequate funding of the anti-doping and clean sport programs of the United States Anti-Doping Agency is imperative to the preparation for the 2028 Summer Olympic Games, which will be held in Los Angeles, California.

“(7)

Increased appropriations for fiscal years 2023 through 2031 would enable the United States Anti-Doping Agency to directly affect the integrity and well-being of sport, both domestically and internationally.”

Credits

2006–2022 · 3 acts
  1. 2006Pub. L. 109–469, title VII, § 701, , 120 Stat. 3533
  2. 2014Pub. L. 113–280, § 2, , 128 Stat. 3020
  3. 2022Pub. L. 117–103, div. Q, title III, § 303, , 136 Stat. 817.
Show as published

(Pub. L. 109–469, title VII, § 701, , 120 Stat. 3533; Pub. L. 113–280, § 2, , 128 Stat. 3020; Pub. L. 117–103, div. Q, title III, § 303, , 136 Stat. 817.)

Parsed from the official OLRC USLM XML in data/usc_all/usc21.xml · release point 119-108 · OLRC build 2026-04-17

USLM identifier /us/usc/t21/s2001